Companies /Healthcare

Canopy Growth Corp

NASDAQ: CGC Drug Manufacturers - Specialty & Generic
$0.55
▼ $0.02 (−2.71%) today
Markets closed · 4:48pm ET

CGC at a Glance

Valuation
Market cap
$252.3M
Profitability
Revenue (TTM)
$308.3M
Profit margin
-88.1%
EPS (TTM)
$-0.51
Price
52-week range
$1 – $2
Street target
$0.91

Headquartered in Smiths Falls, ON Fiscal year ends March NASDAQ: CGC canopygrowth.com

About Canopy Growth

Canopy Growth Corporation (TSX: WEED, Nasdaq: CGC) is a cannabis company that reports two segments: Cannabis and Storz & Bickel.

The Cannabis segment serves three markets:
- Canadian adult-use, through brands including Tweed, 7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL and R'belle. It acquired MTL Cannabis Corp., which added flower supply and medical customers.
- Canadian medical, through Spectrum Therapeutics, Abba Medix, Apollo and Canada House Clinics.
- International medical, with sales in Germany, Poland, Australia and, most recently, the United Kingdom through distribution partner GROW Group. Its Smiths Falls and Kincardine, Ontario facilities hold EU GMP certifications that support an end-to-end EU GMP supply chain for exports to Europe.

Storz & Bickel designs and sells premium cannabis vaporizers globally.

Canopy also holds an unconsolidated, non-controlling interest in Canopy USA, which provides exposure to the U.S. THC market through interests including Wana, Jetty and Acreage. Updated

Latest Activity

CGCCanopy Growth
Q2 2027
EPS
-$0.10
est -$0.03-$0.07
Revenue
$81M
est $82M-0.8%

A $35.8 million fair value charge on Canopy USA assets buried an otherwise real growth quarter, pushing the loss per share to triple consensus. International cannabis revenue jumped 141% on German and Polish medical demand. The CFO still sees positive adjusted EBITDA in fiscal 2027.

Quarterly EPS — reported vs estimate

CGC Coverage

Frequently Asked Questions

What does Canopy Growth do?

Canopy Growth Corporation (TSX: WEED, Nasdaq: CGC) is a cannabis company that reports two segments: Cannabis and Storz & Bickel. The Cannabis segment serves three markets: - Canadian adult-use, through brands including Tweed, 7ACRES, DOJA, Deep Space, DeeLish, Claybourne, MTL Cannabis, Low Key by MTL and R'belle.

What is the CGC stock price target?

The Wall Street consensus 12-month price target for CGC is $0.91.